573
Participants
Start Date
May 31, 2017
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Prednisone
The control intervention (standard treatment) consists of prednisone treatment in decreasing doses, starting with 7.5 mg q.d. and reducing the dose every 7 days, such that prednisone treatment is stopped after a total of 4 weeks.
Placebo Arm
The experimental intervention consists of stopping glucocorticoid treatment abruptly and administering matching placebo over 4 weeks.
RECRUITING
Geneva University Hospitals, Geneva
RECRUITING
Department of Rheumatology, Immunology, and Allergology, Inselspital, Bern
RECRUITING
Endocrinology/Diabetology/Metabolism; University Hospital Basel, Basel
RECRUITING
Center for Primary Health Care,University of Basel, Kantonsspital Baselland, Liestal
RECRUITING
Internal Medicine, Kantonsspital Baselland/Liestal, Liestal
RECRUITING
Stoffwechselzentrum, Kantonsspital Olten, Olten
RECRUITING
Departement of Internal Medicine, Kantonsspital Aarau, Aarau
RECRUITING
Kantonsspital Baden, Baden
RECRUITING
Dept. of Endocrinology, Diabetology and Clinical Nutrition, University Hospital, Zurich
RECRUITING
Division of Gastroenterology, Spital Bülach AG, Bülach
RECRUITING
Kantonsspital Frauenfeld, Frauenfeld
RECRUITING
Department of Internal Medicine, Kantonsspital Münsterlingen, Münsterlingen
RECRUITING
Department of Internal Medicine, Kantonsspital St. Gallen, Sankt Gallen
RECRUITING
University Hospital Würzburg, Würzburg
RECRUITING
University Hospital Frankfurt, Frankfurt
Kantonsspital Baselland Bruderholz
OTHER
Swiss National Science Foundation
OTHER
HEMMI Stiftung Switzerland
UNKNOWN
University Hospital, Basel, Switzerland
OTHER